Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciaa1698
PubMed Identifier: 33200169
Publication URI: http://europepmc.org/abstract/MED/33200169
Type: Journal Article/Review
Volume: 73
Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue: 7
ISSN: 1058-4838